A new bill was introduced on Thursday (June 28) by a leading Democrat in the US Congress seeks to completely decriminalize cannabis.

US Senator Chuck Schumer (D-NY) presented his plan to legalize cannabis across the federal level, unlike the bipartisan bill introduced earlier this month by Senators Elizabeth Warren (D-MA) and Cory Gardner (R-CO), which protected businesses from federal prosecution.


“This legislation is simply the right thing to do and I am hopeful that the balanced approach it takes can earn bipartisan support in Congress and across the country,” Schumer wrote in a statement.

Dubbed the “Marijuana Freedom and Opportunity Act,” this bill will remove cannabis from the list of schedule substances under the Controlled Substances Act (CSA). According to its introduction the bill will still allow the states to decide how to regulate cannabis.

Schumer’s bill will seek to create support grants so local governments can “seal or expunge” cannabis possession conviction records.

A movement of legalization has been gaining momentum throughout the US following an uneasy period of time after Attorney General Jeff Sessions eliminated the Cole memorandum, a government guidance allowing states to dictate their own cannabis law.

Senator Gardner was able agree on a deal with US president Donald Trump, who conceded on allowing the states run their cannabis operations freely. Cannabis has been legalized by nine states both for adult-use and medical, while 29 have legalized it for medical purposes only.

On Monday (June 25) the U.S. Food and Drug Administration (FDA) officially approved Epidiolex, a cannabidiol CBD-based medicine from GW Pharmaceuticals (NASDAQ:GWPH).

“This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies,” FDA commissioner Scott Gottlieb said.

Another major moment for the legalization and establishment of the legal cannabis industry came earlier this year when former Speaker of the United States House of Representatives John Boehner joined the board of advisors for Acreage Holdings, a private US-focused cannabis operator.

Investor takeaway

US operators seeking to raise capital in a favorable investor landscape have made the Canadian Securities Exchange (CSE) their home. Thanks to the potential regulations change, investors and analysts are bullish on these stocks.

In a newsletter emailed to subscribers cannabis analyst with 420 Investor Alan Brochstein wrote the “changing of the political winds out of Washington” have allowed a change in how companies and investors “are thinking about risk.”

Barrington Miller, director of listed company services for the CSE told the Investing News Network (INN) the Canadian exchange has seen an increased momentum for cannabis stocks thanks to the changing ways in the US.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Both locations expand access to the state’s widest-ranging inventory of medical cannabis products for Central Florida patients

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of two brand-new Central Florida dispensaries. The new Clearwater and Tampa locations mark the Company’s 81 st and 82 nd nationwide, respectively, widening patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce the appointment of Bart Oates Esq., President of the NFL Alumni Association, to its Advisory Board.

Philip Young, CEO and Director of Lobe, stated, “We are honored to welcome Bart to our Advisory Board. His first-hand experience on and off the field are tremendously valuable as we continue our research involving mild traumatic brain injuries and PTSD. These issues are prevalent in contact sports and we believe that athletes will play a prominent role in the continued acceptance of psychedelic medicines as legitimate treatment. We look forward to working with Bart as we seek to forge long-term strategic relationships.”

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has submitted its dossier to the United Kingdom’s Regulatory Food Safety Agency (the “FSA”).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005322/en/

Keep reading... Show less